You Position: Home > Paper
The current best evidence of systemic treatment for plaque psoriasis
( views:323, downloads:170 )
- Author:
- No author available
- Journal Title:
- INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY
- Issue:
- 2
- DOI:
- 10.3760/cma.j.issn.1673-4173.2007.02.005
- Key Word:
- 银屑病;治疗;系统评价;随机对照试验
Abstract： 系统评价或荟萃分析结果以及大样本多中心随机对照试验被认为是最佳证据.银屑病最常见的类型是斑块状银屑病,系统治疗斑块状银屑病的药物主要是甲氨蝶呤、环孢素和维A酸类药物.近几年生物制剂成为新的研究热点,已有多个随机对照试验为生物制剂的疗效和安伞性提供了良好的证据.概括这些药物治疗斑块状银屑病的系统评价/荟萃分析和多中心随机对照试验结果,为临床提供最佳证据.
- [1]管红珍,彭智聪,傅鹰.循证医学中文献证据等级标准的系统性综述[J].2002,(3).
- [2]Papp K,Zitnik R,Leonardi C,etc.Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.[J].2006,367(9504).
- [3]Craig L, Leonardi,Kim A, Papp,Kenneth B, Gordon,etc.Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.[J].2005,52(3 Pt 1).
- [4]K.A. Papp,S. Tyring,M. Lahfa,etc.A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction[J].2005,152(6).
- [5]J-P, Ortonne.Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis.[J].2003,17 Suppl 2.
- [6]Gerald G. Krueger,Kim A. Papp,Dow B. Stough,etc.A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis[J].2002,47(6).
- [7]Lothar Faerber,Dr Matthias Braeutigam,Gottfried Weidinger,etc.Cyclosporine in Severe Psoriasis[J].2001,2(1).
- [8]Papp K,Li S,Reich K,etc.Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.[J].2005,366(9494).
- [9]Lebwohl M.Psoriasis.[J].2003,361(9364).
- [10]Zitnik R,Wang A,Leonardi CL,etc.Etanercept as monotherapy in patients with psoriasis.[J].2003,349(21).
- [11]Baker DG,Chaudhari U,Romano P,etc.Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.[J].2001,357(9271).
- [12]C E, Griffiths,C M, Clark,R J, Chalmers,etc.A systematic review of treatments for severe psoriasis.[J].2000,4(40).
- [13]Alice B. Gottlieb,Robert Evans,Shu Li,etc.Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial[J].2004,51(4).
- [14]Alan, Menter,Kenneth, Gordon,Wayne, Carey,etc.Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.[J].2005,141(1).
- [15]Tawfik NH,Wang X,Toth D,etc.A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.[J].2003,349(21).
- [16]Krueger GG,Ellis CN.Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.[J].2001,345(4).
- [17]Heydendael VM,Spuls PI,Opmeer BC,etc.Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.[J].2003,349(7).
- [18]Ohtsuki M,Nakagawa H,Sugai J,etc.Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.[J].2003,30(4).
- [19]Alice B, Gottlieb,Robert T, Matheson,Nicholas, Lowe,etc.A randomized trial of etanercept as monotherapy for psoriasis.[J].2003,139.
- [20]P.I. SPULS,L. WITKAMP,P.M.M. BOSSUYT,etc.A systematic review of five systemic treatments for severe psoriasis[J].1997,137(6).